Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 Jul;94(1):361–367. doi: 10.1172/JCI117330

Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway.

T Imamura 1, R N Pike 1, J Potempa 1, J Travis 1
PMCID: PMC296317  PMID: 8040277

Abstract

To elucidate the mechanism of production of an inflammatory exudate, gingival crevicular fluid (GCF), from periodontal pockets in periodontitis, we examined the vascular permeability enhancement (VPE) activity induced by an arginine-specific cysteine proteinase, Arg-gingipain-1 (RGP-1), produced by a major periopathogenic bacterium, Porphyromonas gingivalis. Intradermal injections into guinea pigs of RGP-1 (> 10(-8) M), or human plasma incubated with RGP-1 (> 10(-9) M), induced VPE in a dose- and activity-dependent manner but with different time courses for the two routes of production. VPE activity induced by RGP-1 was augmented by kininase inhibitors, inhibited by a kallikrein inhibitor and unaffected by an antihistamine drug. The VPE activity in human plasma incubated with RGP-1 also correlated closely with generation of bradykinin (BK). RGP-1 induced 30-40% less VPE activity in Hageman factor-deficient plasma and no VPE in plasma deficient in either prekallikrein (PK) or high molecular weight kininogen (HMWK). After incubation with RGP-1, plasma deficient in PK or HMWK, reconstituted with each missing protein, caused VPE, as did a mixture of purified PK and HMWK, but RGP-1 induced no VPE from HMWK. The VPE of extracts of clinically isolated P. gingivalis were reduced to about 10% by anti-RGP-1-IgG, leupeptin, or tosyl-L-lysine chloromethyl ketone, which paralleled effects observed with RGP-1. These results indicate that RGP-1 is the major VPE factor of P. gingivalis, inducing this activity through PK activation and subsequent BK release, resulting in GCF production at sites of periodontitis caused by infection with this organism.

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkedal-Hansen H., Taylor R. E., Zambon J. J., Barwa P. K., Neiders M. E. Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodontal Res. 1988 Jul;23(4):258–264. doi: 10.1111/j.1600-0765.1988.tb01369.x. [DOI] [PubMed] [Google Scholar]
  2. Bouma B. N., Kerbiriou D. M., Vlooswijk R. A., Griffin J. H. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation. J Lab Clin Med. 1980 Oct;96(4):693–709. [PubMed] [Google Scholar]
  3. Bouma B. N., Miles L. A., Beretta G., Griffin J. H. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate. Biochemistry. 1980 Mar 18;19(6):1151–1160. doi: 10.1021/bi00547a018. [DOI] [PubMed] [Google Scholar]
  4. Brecx M. C., Schlegel K., Gehr P., Lang N. P. Comparison between histological and clinical parameters during human experimental gingivitis. J Periodontal Res. 1987 Jan;22(1):50–57. doi: 10.1111/j.1600-0765.1987.tb01539.x. [DOI] [PubMed] [Google Scholar]
  5. Chen P. B., Davern L. B., Schifferle R., Zambon J. J. Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection. Infect Immun. 1990 Oct;58(10):3394–3400. doi: 10.1128/iai.58.10.3394-3400.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen Z., Potempa J., Polanowski A., Wikstrom M., Travis J. Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem. 1992 Sep 15;267(26):18896–18901. [PubMed] [Google Scholar]
  7. Chung D. W., Fujikawa K., McMullen B. A., Davie E. W. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry. 1986 May 6;25(9):2410–2417. doi: 10.1021/bi00357a017. [DOI] [PubMed] [Google Scholar]
  8. Cochrane C. G., Revak S. D., Wuepper K. D. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med. 1973 Dec 1;138(6):1564–1583. doi: 10.1084/jem.138.6.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dunn J. T., Silverberg M., Kaplan A. P. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. J Biol Chem. 1982 Feb 25;257(4):1779–1784. [PubMed] [Google Scholar]
  10. Engel S. L., Schaeffer T. R., Gold B. I., Rubin B. Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides. Proc Soc Exp Biol Med. 1972 May;140(1):240–244. doi: 10.3181/00379727-140-36433. [DOI] [PubMed] [Google Scholar]
  11. Evans R. T., Klausen B., Sojar H. T., Bedi G. S., Sfintescu C., Ramamurthy N. S., Golub L. M., Genco R. J. Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun. 1992 Jul;60(7):2926–2935. doi: 10.1128/iai.60.7.2926-2935.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grenier D., Mayrand D. Selected characteristics of pathogenic and nonpathogenic strains of Bacteroides gingivalis. J Clin Microbiol. 1987 Apr;25(4):738–740. doi: 10.1128/jcm.25.4.738-740.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Henskens Y. M., van der Velden U., Veerman E. C., Nieuw Amerongen A. V. Protein, albumin and cystatin concentrations in saliva of healthy subjects and of patients with gingivitis or periodontitis. J Periodontal Res. 1993 Jan;28(1):43–48. doi: 10.1111/j.1600-0765.1993.tb01049.x. [DOI] [PubMed] [Google Scholar]
  14. Hinode D., Hayashi H., Nakamura R. Purification and characterization of three types of proteases from culture supernatants of Porphyromonas gingivalis. Infect Immun. 1991 Sep;59(9):3060–3068. doi: 10.1128/iai.59.9.3060-3068.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hinode D., Nagata A., Ichimiya S., Hayashi H., Morioka M., Nakamura R. Generation of plasma kinin by three types of protease isolated from Porphyromonas gingivalis 381. Arch Oral Biol. 1992 Oct;37(10):859–861. doi: 10.1016/0003-9969(92)90120-w. [DOI] [PubMed] [Google Scholar]
  16. Holt S. C., Ebersole J., Felton J., Brunsvold M., Kornman K. S. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science. 1988 Jan 1;239(4835):55–57. doi: 10.1126/science.3336774. [DOI] [PubMed] [Google Scholar]
  17. Hugli T. E. Biochemistry and biology of anaphylatoxins. Complement. 1986;3(3):111–127. doi: 10.1159/000467889. [DOI] [PubMed] [Google Scholar]
  18. Imamura T., Yamamoto T., Kambara T. Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo. Am J Pathol. 1984 Apr;115(1):92–101. [PMC free article] [PubMed] [Google Scholar]
  19. Kellermann J., Lottspeich F., Henschen A., Müller-Esterl W. Completion of the primary structure of human high-molecular-mass kininogen. The amino acid sequence of the entire heavy chain and evidence for its evolution by gene triplication. Eur J Biochem. 1986 Jan 15;154(2):471–478. doi: 10.1111/j.1432-1033.1986.tb09421.x. [DOI] [PubMed] [Google Scholar]
  20. Kesavalu L., Ebersole J. L., Machen R. L., Holt S. C. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun. 1992 Apr;60(4):1455–1464. doi: 10.1128/iai.60.4.1455-1464.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. LOE H., HOLM-PEDERSEN P. ABSENCE AND PRESENCE OF FLUID FROM NORMAL AND INFLAMED GINGIVAE. Periodontics. 1965 Jul-Aug;3:171–177. [PubMed] [Google Scholar]
  22. Mandle R., Jr, Kaplan A. P. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977 Sep 10;252(17):6097–6104. [PubMed] [Google Scholar]
  23. Marsh P. D., McKee A. S., McDermid A. S., Dowsett A. B. Ultrastructure and enzyme activities of a virulent and an avirulent variant of Bacteroides gingivalis W50. FEMS Microbiol Lett. 1989 May;50(1-2):181–185. doi: 10.1016/0378-1097(89)90482-5. [DOI] [PubMed] [Google Scholar]
  24. Maruo K., Akaike T., Inada Y., Ohkubo I., Ono T., Maeda H. Effect of microbial and mite proteases on low and high molecular weight kininogens. Generation of kinin and inactivation of thiol protease inhibitory activity. J Biol Chem. 1993 Aug 25;268(24):17711–17715. [PubMed] [Google Scholar]
  25. Maruo K., Akaike T., Matsumura Y., Kohmoto S., Inada Y., Ono T., Arao T., Maeda H. Triggering of the vascular permeability reaction by activation of the Hageman factor-prekallikrein system by house dust mite proteinase. Biochim Biophys Acta. 1991 May 24;1074(1):62–68. doi: 10.1016/0304-4165(91)90040-n. [DOI] [PubMed] [Google Scholar]
  26. Matsumoto K., Yamamoto T., Kamata R., Maeda H. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease. J Biochem. 1984 Sep;96(3):739–749. doi: 10.1093/oxfordjournals.jbchem.a134892. [DOI] [PubMed] [Google Scholar]
  27. Minhas T., Greenman J. Production of cell-bound and vesicle-associated trypsin-like protease, alkaline phosphatase and N-acetyl-beta-glucosaminidase by Bacteroides gingivalis strain W50. J Gen Microbiol. 1989 Mar;135(3):557–564. doi: 10.1099/00221287-135-3-557. [DOI] [PubMed] [Google Scholar]
  28. Molla A., Yamamoto T., Akaike T., Miyoshi S., Maeda H. Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J Biol Chem. 1989 Jun 25;264(18):10589–10594. [PubMed] [Google Scholar]
  29. Nilsson T., Carlsson J., Sundqvist G. Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis. Infect Immun. 1985 Nov;50(2):467–471. doi: 10.1128/iai.50.2.467-471.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Oliver R. C., Holm-Pederen P., Löe H. The correlation between clinical scoring, exudate measurements and microscopic evaluation of inflammation in the gingiva. J Periodontol. 1969 Apr;40(4):201–209. doi: 10.1902/jop.1969.40.4.201. [DOI] [PubMed] [Google Scholar]
  31. POLSON A., POTGIETER G. M., LARGIER J. F., MEARS G. E., JOUBERT F. J. THE FRACTIONATION OF PROTEIN MIXTURES BY LINEAR POLYMERS OF HIGH MOLECULAR WEIGHT. Biochim Biophys Acta. 1964 Mar 16;82:463–475. doi: 10.1016/0304-4165(64)90438-6. [DOI] [PubMed] [Google Scholar]
  32. Rüdin H. J., Overdiek H. F., Rateitschak K. H. Correlation between sulcus fluid rate and clinical and histological inflammation of the marginal gingiva. Helv Odontol Acta. 1970 Apr;14(1):21–26. [PubMed] [Google Scholar]
  33. Schenkein H. A., Berry C. R. Production of chemotactic factors for neutrophils following the interaction of Bacteroides gingivalis with purified C5. J Periodontal Res. 1988 Sep;23(5):308–312. doi: 10.1111/j.1600-0765.1988.tb01422.x. [DOI] [PubMed] [Google Scholar]
  34. Scott C. F., Whitaker E. J., Hammond B. F., Colman R. W. Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. J Biol Chem. 1993 Apr 15;268(11):7935–7942. [PubMed] [Google Scholar]
  35. Senior R. M., Skogen W. F., Griffin G. L., Wilner G. D. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest. 1986 Mar;77(3):1014–1019. doi: 10.1172/JCI112353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Shaw J. H. Causes and control of dental caries. N Engl J Med. 1987 Oct 15;317(16):996–1004. doi: 10.1056/NEJM198710153171605. [DOI] [PubMed] [Google Scholar]
  37. Shibuya Y., Tanaka H., Nishino N., Okabe H., Kambara T., Yamamoto T. Activation of human plasma prekallikrein by Pseudomonas aeruginosa elastase in vitro. Biochim Biophys Acta. 1991 Jul 26;1097(1):23–27. doi: 10.1016/0925-4439(91)90018-5. [DOI] [PubMed] [Google Scholar]
  38. Slots J. The predominant cultivable microflora of advanced periodontitis. Scand J Dent Res. 1977 Jan-Feb;85(2):114–121. doi: 10.1111/j.1600-0722.1977.tb00541.x. [DOI] [PubMed] [Google Scholar]
  39. Smalley J. W., Birss A. J., Kay H. M., McKee A. S., Marsh P. D. The distribution of trypsin-like enzyme activity in cultures of a virulent and an avirulent strain of Bacteroides gingivalis W50. Oral Microbiol Immunol. 1989 Sep;4(3):178–181. doi: 10.1111/j.1399-302x.1989.tb00249.x. [DOI] [PubMed] [Google Scholar]
  40. Smalley J. W., Birss A. J. Trypsin-like enzyme activity of the extracellular membrane vesicles of Bacteroides gingivalis W50. J Gen Microbiol. 1987 Oct;133(10):2883–2894. doi: 10.1099/00221287-133-10-2883. [DOI] [PubMed] [Google Scholar]
  41. Spiegel C. A., Hayduk S. E., Minah G. E., Krywolap G. N. Black-pigmented Bacteroides from clinically characterized periodontal sites. J Periodontal Res. 1979 Sep;14(5):376–382. doi: 10.1111/j.1600-0765.1979.tb00234.x. [DOI] [PubMed] [Google Scholar]
  42. Sundqvist G., Bengtson A., Carlsson J. Generation and degradation of the complement fragment C5a in human serum by Bacteroides gingivalis. Oral Microbiol Immunol. 1988 Sep;3(3):103–107. doi: 10.1111/j.1399-302x.1988.tb00093.x. [DOI] [PubMed] [Google Scholar]
  43. Sundqvist G., Carlsson J., Herrmann B., Tärnvik A. Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J Med Microbiol. 1985 Feb;19(1):85–94. doi: 10.1099/00222615-19-1-85. [DOI] [PubMed] [Google Scholar]
  44. Sundqvist G., Carlsson J., Hänström L. Collagenolytic activity of black-pigmented Bacteroides species. J Periodontal Res. 1987 Jul;22(4):300–306. doi: 10.1111/j.1600-0765.1987.tb01589.x. [DOI] [PubMed] [Google Scholar]
  45. Takahashi K., Aoki T., Kohmoto S., Nishimura H., Kodera Y., Matsushima A., Inada Y. Activation of kallikrein-kinin system in human plasma with purified serine protease from Dermatophagoides farinae. Int Arch Allergy Appl Immunol. 1990;91(1):80–85. doi: 10.1159/000235094. [DOI] [PubMed] [Google Scholar]
  46. Tanaka H., Yamamoto T., Shibuya Y., Nishino N., Tanase S., Miyauchi Y., Kambara T. Activation of human plasma prekallikrein by Pseudomonas aeruginosa elastase. II. Kinetic analysis and identification of scissile bond of prekallikrein in the activation. Biochim Biophys Acta. 1992 Mar 20;1138(3):243–250. doi: 10.1016/0925-4439(92)90044-n. [DOI] [PubMed] [Google Scholar]
  47. Tanner A. C., Haffer C., Bratthall G. T., Visconti R. A., Socransky S. S. A study of the bacteria associated with advancing periodontitis in man. J Clin Periodontol. 1979 Oct;6(5):278–307. doi: 10.1111/j.1600-051x.1979.tb01931.x. [DOI] [PubMed] [Google Scholar]
  48. Udaka K., Takeuchi Y., Movat H. Z. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970 Apr;133(4):1384–1387. doi: 10.3181/00379727-133-34695. [DOI] [PubMed] [Google Scholar]
  49. White D., Mayrand D. Association of oral Bacteroides with gingivitis and adult periodontitis. J Periodontal Res. 1981 May;16(3):259–265. doi: 10.1111/j.1600-0765.1981.tb00974.x. [DOI] [PubMed] [Google Scholar]
  50. Williams R. C. Periodontal disease. N Engl J Med. 1990 Feb 8;322(6):373–382. doi: 10.1056/NEJM199002083220606. [DOI] [PubMed] [Google Scholar]
  51. Wingrove J. A., DiScipio R. G., Chen Z., Potempa J., Travis J., Hugli T. E. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem. 1992 Sep 15;267(26):18902–18907. [PubMed] [Google Scholar]
  52. Wuepper K. D., Cochrane C. G. Plasma prekallikrein: isolation, characterization, and mechanism of activation. J Exp Med. 1972 Jan;135(1):1–20. doi: 10.1084/jem.135.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Yamamoto T., Kozono K., Kambara T., Cochrane C. G. The Hageman factor-dependent system in the vascular permeability reaction. Biochim Biophys Acta. 1988 Aug 11;966(2):196–206. doi: 10.1016/0304-4165(88)90112-2. [DOI] [PubMed] [Google Scholar]
  54. Yamamoto T., Shibuya Y., Nishino N., Okabe H., Kambara T. Activation of human Hageman factor by Pseudomonas aeruginosa elastase in the presence or absence of negatively charged substance in vitro. Biochim Biophys Acta. 1990 Apr 19;1038(2):231–239. doi: 10.1016/0167-4838(90)90210-7. [DOI] [PubMed] [Google Scholar]
  55. Yang H. Y., Erdös E. G. Second kininase in human blood plasma. Nature. 1967 Sep 23;215(5108):1402–1403. doi: 10.1038/2151402a0. [DOI] [PubMed] [Google Scholar]
  56. Zambon J. J., Reynolds H. S., Slots J. Black-pigmented Bacteroides spp. in the human oral cavity. Infect Immun. 1981 Apr;32(1):198–203. doi: 10.1128/iai.32.1.198-203.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES